RxDoctor Payments Data

Nicolette Hampton, NP

Family · Pocatello, IDNPI 1184083818

Payments from drug & device makers

$1,823in general payments, 2019–2025

Across 105 payments — averaging $17.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$578
  • Astellas Pharma US Inc$252
  • Amgen$181
  • Grifols USA, LLC$127
  • Novo Nordisk$98
  • Xeris Pharmaceuticals, Inc.$82
  • plus $505 from 18 others

What the payments were for

  • Food & beverage$1,823100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,823 in reported general payments places this provider in the 80th percentile of 809 family providers in Idaho.

See all family providers in Idaho

Medicare billing

Part B allowed, 2024
$118,213
Medicare patients
106
Services billed
14,077

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide26$33,440
EliquisApixaban27$33,032
OzempicSemaglutide14$20,458
TopamaxTopiramate13$9,778
Buprenorphine15$6,774
Tresiba Flextouch U-100Insulin Degludec13$6,444
Celecoxib26$2,105
Estradiol28$1,984
Omeprazole135$1,138
Levothyroxine Sodium158$1,096
Potassium Chloride36$1,063
Estradiol (Once Weekly)Estradiol11$941
Atorvastatin Calcium105$846
Gabapentin45$799
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine12$789

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$57$33,44026 claims
PfizerEliquis$28$33,03227 claims
Novo NordiskOzempic$98$20,45814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 809 family providers in Idaho.

Other family in Pocatello

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →